Thanks for pointing that out. I was trying to be slightly facetious in my post by quoting CB Pharma's November 25, 2015 press release that included the November 18, 2015 letter to National Holdings' Chairman. It stated, "The offer price in cash represents a 32% premium over the Company's closing price on November 17, 2015. The offer price in stock of CB represents a 42% premium over the Company's closing price on November 17, 2015."
It is such a silly statement on the face of it. NHLD is a low volume stock, and the difference between the bid and the ask can consume most of CB's "premium". At one point during the week prior to the offer, NHLD had a bid-ask spread of more than 20%. That is the reason I put quotes around the word "premium".
<<Weiss and Rosenwald are not strangers to NHLD, and CB’s 32%-42% "premium" offer price is severely lacking.>>
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM